VivoSim Labs, Inc. Derivative Liability, Current
VivoSim Labs, Inc. (VIVS) had Derivative Liability, Current of $0 as of 2017-03-31, per its 10-K filed 2017-06-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2017-06-07
- 2017-03-31: Derivative Liability, Current $0.00.
- 2016-12-31: Derivative Liability, Current $8.00K.
- 2016-09-30: Derivative Liability, Current $9.00K.
- 2016-06-30: Derivative Liability, Current $9.00K.
| Period end | Derivative Liability, Current |
|---|---|
| 2017-03-31 | $0.00 10-K · filed 2017-06-07 |
| 2016-12-31 | $8.00K 10-Q · filed 2017-02-09 |
| 2016-09-30 | $9.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $9.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $4.00K 10-K · filed 2017-06-07 |
| 2015-12-31 | $14.00K 10-Q · filed 2016-02-08 |
| 2015-09-30 | $16.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $26.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $126.00K 10-K · filed 2016-06-09 |
| 2014-12-31 | $298.00K 10-Q · filed 2015-02-06 |
| 2014-09-30 | $258.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $352.00K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $377.00K 10-K · filed 2015-06-09 |
| 2013-12-31 | $1.01M 10-Q · filed 2014-02-06 |
| 2013-09-30 | $795.00K 10-Q · filed 2013-11-08 |
| 2013-06-30 | $6.03M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $6.90M 10-K · filed 2014-06-10 |
| 2012-12-31 | $20.62M 10-K · filed 2014-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |